Hematopoietic Cell Transplantation in the Management of Myelodysplastic Syndrome: An Evidence-Based Review from the American Society for Transplantation and Cellular Therapy Committee on Practice Guidelines-Reference-Cited by-同舟云学术

Hematopoietic Cell Transplantation in the Management of Myelodysplastic Syndrome: An Evidence-Based Review from the American Society for Transplantation and Cellular Therapy Committee on Practice Guidelines

Published:2023-02 Issue:2 Volume:29 Page:71-81
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

DeFilipp Zachariah^ORCID,Ciurea Stefan O.,Cutler Corey^ORCID,Robin Marie,Warlick Erica D.,Nakamura Ryotaro,Brunner Andrew M.,Dholaria Bhagirathbhai,Walker Alison R.,Kröger Nicolaus^ORCID,Bejanyan Nelli^ORCID,Atallah Ehab,Tamari Roni,Solh Melhem M.,Percival Mary-Elizabeth,de Lima Marcos^ORCID,Scott Bart,Oran Betul,Garcia-Manero Guillermo,Hamadani Mehdi^ORCID,Carpenter Paul,DeZern Amy E.

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference122 articles.

1. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review;Oliansky;Biol Blood Marrow Transplant,2009

2. Hematopoietic cell transplantation in the treatment of pediatric acute myeloid leukemia and myelodysplastic syndromes: guidelines from the American Society of Transplantation and Cellular Therapy;Tarlock;Transplant Cell Ther,202228530

3. A new system for grading recommendations in evidence based guidelines;Harbour;BMJ,2001

4. Methodology for updating published evidence-based reviews evaluating the role of blood and marrow transplantation in the treatment of selected diseases: a policy statement by the American Society for Blood and Marrow Transplantation;Jones;Biol Blood Marrow Transplant,2009

5. Systematic reviews in hematopoietic cell transplantation and cellular therapy: considerations and guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research late effects and quality of life working committee

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Pharmacokinetics of Briquilimab as a Conditioning Agent for Hematopoietic Stem Cell Transplantation in Patients With Severe Combined Immunodeficiency, Myelodysplastic Syndrome, or Acute Myeloid Leukemia;Transplantation and Cellular Therapy;2024-09

3. Current challenges in conditioning regimens for MDS transplantation;Blood Reviews;2024-09

4. Revisiting Timing and Decision Modeling for Allogeneic Hematopoietic Stem-Cell Transplantation in Myelodysplastic Syndromes;Journal of Clinical Oncology;2024-08-20

5. Beyond HMAs: Novel targets and therapeutic approaches;Seminars in Hematology;2024-08